Details for New Drug Application (NDA): 050536
✉ Email this page to a colleague
The generic ingredient in ERYC is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 050536
Tradename: | ERYC |
Applicant: | Dr Reddys Labs Sa |
Ingredient: | erythromycin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050536
Suppliers and Packaging for NDA: 050536
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ERYC | erythromycin | CAPSULE, DELAYED REL PELLETS;ORAL | 050536 | NDA AUTHORIZED GENERIC | Mayne Pharma Inc. | 68308-250 | 68308-250-10 | 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (68308-250-10) |
ERYC | erythromycin | CAPSULE, DELAYED REL PELLETS;ORAL | 050536 | NDA AUTHORIZED GENERIC | Dr. Reddy's Labratories Inc. | 75907-076 | 75907-076-01 | 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (75907-076-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | 250MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes |
Complete Access Available with Subscription